| scholarly article | Q13442814 |
| P50 | author | Alexander N. Zelikin | Q39935869 |
| Rona Chandrawati | Q42290270 | ||
| P2093 | author name string | Tao Yang | |
| P2860 | cites work | Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study | Q46237233 |
| Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles | Q47212567 | ||
| Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapy | Q47681284 | ||
| Endothelial Glycocalyx-Mediated Nitric Oxide Production in Response to Selective AFM Pulling | Q47932144 | ||
| Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives | Q47946155 | ||
| Peptide-Functionalized Fluorescent Particles for In Situ Detection of Nitric Oxide via Peroxynitrite-Mediated Nitration. | Q48133884 | ||
| Enzyme prodrug therapies and therapeutic enzymes. | Q50062110 | ||
| Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations. | Q50062438 | ||
| Enzymes as key features in therapeutic cell mimicry. | Q50062454 | ||
| Controlled assembly of peptide-functionalized gold nanoparticles for label-free detection of blood coagulation Factor XIII activity. | Q50477135 | ||
| Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin. | Q51053760 | ||
| Immobilization of Metal-Organic Framework Copper(II) Benzene-1,3,5-tricarboxylate (CuBTC) onto Cotton Fabric as a Nitric Oxide Release Catalyst. | Q51634036 | ||
| Pharmaceutical Approval Update. | Q51768640 | ||
| Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. | Q52241033 | ||
| Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug. | Q52941257 | ||
| Lipophilic ruthenium salen complexes: incorporation into liposome bilayers and photoinduced release of nitric oxide. | Q53610441 | ||
| Delivery of nitric oxide released from beta-Gal-NONOate activation by beta-galactosidase and its activity against Escherichia coli. | Q54464040 | ||
| Stabilization of Polymer-Hydrogel Capsules via Thiolâ Disulfide Exchange | Q56769296 | ||
| The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium | Q69813452 | ||
| Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity | Q73390448 | ||
| Catalytic generation of nitric oxide from S-nitrosothiols using immobilized organoselenium species | Q80227934 | ||
| Sialated diazeniumdiolate: a new sialidase-activated nitric oxide donor | Q80956405 | ||
| Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents | Q82532853 | ||
| Cardiology patient page. Managing your angina symptoms with nitroglycerin: what about exercise? | Q86893874 | ||
| Nitric oxide-releasing quaternary ammonium-modified poly(amidoamine) dendrimers as dual action antibacterial agents | Q87813289 | ||
| Nitric oxide and peroxynitrite in health and disease | Q24645400 | ||
| Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances | Q27015464 | ||
| Development of novel FP-based probes for live-cell imaging of nitric oxide dynamics | Q27333473 | ||
| Nitric oxide and virus infection | Q27485884 | ||
| Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery | Q28085438 | ||
| The molecule of the year | Q28237487 | ||
| Nitric oxide synthases: regulation and function | Q28247092 | ||
| Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly | Q29547442 | ||
| Nitric oxide and the immune response | Q29617591 | ||
| Localized cell stimulation by nitric oxide using a photoactive porous coordination polymer platform | Q30557236 | ||
| Immunological properties of gold nanoparticles | Q33578950 | ||
| Nitric oxide metabolism and breakdown. | Q33631322 | ||
| Improved Hemocompatibility of Multilumen Catheters via Nitric Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP) Composite Filled Lumen | Q33647184 | ||
| Generic nitric oxide (NO) generating surface by immobilizing organoselenium species via layer-by-layer assembly | Q33666779 | ||
| Inhibition of influenza virus replication by nitric oxide | Q33821697 | ||
| Nitric oxide donors: chemical activities and biological applications | Q33958494 | ||
| Diazeniumdiolates: pro- and antioxidant applications of the "NONOates". | Q33991762 | ||
| Role of nitric oxide in wound repair | Q34125425 | ||
| Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo | Q34894458 | ||
| Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical Translation | Q35438759 | ||
| Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity | Q35542339 | ||
| Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles | Q35575785 | ||
| A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study | Q35677641 | ||
| Breathing new life into nitric oxide signaling: A brief overview of the interplay between oxygen and nitric oxide | Q35757318 | ||
| eNOS, a pressure-dependent regulator of intraocular pressure. | Q35801497 | ||
| Nitric oxide release: part III. Measurement and reporting | Q35925885 | ||
| Role of nitric oxide in murine conventional outflow physiology | Q35958562 | ||
| Recent developments in nitric oxide donor drugs. | Q36052815 | ||
| Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension | Q36108034 | ||
| S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley Catheters: A Potential Biomaterial/Device To Prevent Catheter-Associated Urinary Tract Infections | Q36121146 | ||
| Nitric oxide-releasing dendrimers as antibacterial agents | Q36352418 | ||
| Dual action antimicrobials: nitric oxide release from quaternary ammonium-functionalized silica nanoparticles | Q36352429 | ||
| Anti-biofilm action of nitric oxide-releasing alkyl-modified poly(amidoamine) dendrimers against Streptococcus mutans | Q36416219 | ||
| The role of nitric oxide in tumour progression | Q36516414 | ||
| Functionalized Mesoporous Silica via an Aminosilane Surfactant Ion Exchange Reaction: Controlled Scaffold Design and Nitric Oxide Release | Q36525422 | ||
| An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer | Q36739148 | ||
| Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity | Q36946565 | ||
| The chemical biology of nitric oxide: implications in cellular signaling | Q36948369 | ||
| Hydrolytic reactivity trends among potential prodrugs of the O2-glycosylated diazeniumdiolate family. Targeting nitric oxide to macrophages for antileishmanial activity | Q36952312 | ||
| Concepts of neural nitric oxide-mediated transmission | Q37029494 | ||
| Nonporous Silica Nanoparticles for Nanomedicine Application. | Q37131939 | ||
| Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin | Q37159291 | ||
| Gold nanoparticles in delivery applications | Q37191739 | ||
| Nitric oxide-releasing amphiphilic poly(amidoamine) (PAMAM) dendrimers as antibacterial agents | Q37274077 | ||
| Cerebral blood flow regulation by nitric oxide: recent advances | Q37416850 | ||
| Competitive formation of N-diazeniumdiolates and N-nitrosamines via anaerobic reactions of polyamines with nitric oxide | Q37456817 | ||
| Complexity in biomaterials for tissue engineering. | Q37490816 | ||
| Nitroprusside in decompensated heart failure: what should a clinician really know? | Q37590474 | ||
| The forthcoming applications of gold nanoparticles in drug and gene delivery systems. | Q37651864 | ||
| Drug releasing polymer thin films: new era of surface-mediated drug delivery | Q37737717 | ||
| Mesoporous silica nanoparticles for intracellular controlled drug delivery. | Q37778327 | ||
| Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
| Nitric oxide donors for cardiovascular implant applications | Q38058487 | ||
| Designing regenerative biomaterial therapies for the clinic. | Q38059838 | ||
| Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview | Q38082235 | ||
| Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers | Q38141564 | ||
| Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study | Q38414245 | ||
| New Developments in Liposomal Drug Delivery | Q38502540 | ||
| Strategies to increase nitric oxide signalling in cardiovascular disease | Q38565004 | ||
| Nanomedicine Applications of Hybrid Nanomaterials Built from Metal-Ligand Coordination Bonds: Nanoscale Metal-Organic Frameworks and Nanoscale Coordination Polymers | Q38574838 | ||
| Nitric Oxide Releasing Hydrogel Promotes Endothelial Differentiation of Mouse Embryonic Stem Cells. | Q38599328 | ||
| Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery | Q38663819 | ||
| Metal-Organic Framework/Chitosan Hybrid Materials Promote Nitric Oxide Release from S-Nitrosoglutathione in Aqueous Solution. | Q38761148 | ||
| Encapsulation of N-Diazeniumdiolates within Liposomes for Enhanced Nitric Oxide Donor Stability and Delivery | Q38842560 | ||
| Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO). | Q38844542 | ||
| Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents | Q38861841 | ||
| Anti-Biofilm Efficacy of Dual-Action Nitric Oxide-Releasing Alkyl Chain Modified Poly(amidoamine) Dendrimers | Q38887245 | ||
| Multifunctional metal-organic framework catalysts: synergistic catalysis and tandem reactions | Q39007600 | ||
| Gradual release of strongly bound nitric oxide from Fe₂(NO)₂(dobdc). | Q39035955 | ||
| Nitroreductase-activated nitric oxide (NO) prodrugs | Q39094084 | ||
| β-galactosyl-pyrrolidinyl diazeniumdiolate: an efficient tool to investigate nitric oxide functions on promoting cell death | Q39134975 | ||
| Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. | Q39139744 | ||
| INDQ/NO, a bioreductively activated nitric oxide prodrug | Q39154296 | ||
| Synergistic interaction of β-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells | Q39180937 | ||
| Substrate mediated enzyme prodrug therapy. | Q39273662 | ||
| Liposomes and lipid bilayers in biosensors. | Q39364859 | ||
| Prodrugs in medicinal chemistry and enzyme prodrug therapies | Q39414016 | ||
| Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake | Q39423946 | ||
| Transition-Metal-Mediated Release of Nitric Oxide (NO) from S-Nitroso-N-acetyl-d-penicillamine (SNAP): Potential Applications for Endogenous Release of NO at the Surface of Stents Via Corrosion Products | Q39875088 | ||
| Metal-Organic Frameworks as Platforms for Functional Materials. | Q39996410 | ||
| A multi-defense strategy: Enhancing bactericidal activity of a medical grade polymer with a nitric oxide donor and surface-immobilized quaternary ammonium compound | Q40185636 | ||
| Superoxide fluxes limit nitric oxide-induced signaling | Q40257194 | ||
| A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity. | Q40265854 | ||
| Reduction of Thrombosis and Bacterial Infection via Controlled Nitric Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated CarboSil Intravascular Catheters | Q40288832 | ||
| Inhibition of bacterial adhesion and biofilm formation by dual functional textured and nitric oxide releasing surfaces | Q40372225 | ||
| Attenuation of thrombosis and bacterial infection using dual function nitric oxide releasing central venous catheters in a 9day rabbit model. | Q40582484 | ||
| Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study | Q40798144 | ||
| Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles. | Q40811988 | ||
| Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver | Q41104171 | ||
| Enzyme Prodrug Therapy Engineered into Electrospun Fibers with Embedded Liposomes for Controlled, Localized Synthesis of Therapeutics | Q41502443 | ||
| Cell-Mediated Enzyme Prodrug Cancer Therapies | Q41936418 | ||
| Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier | Q42153590 | ||
| Water-Stable Metal-Organic Framework/Polymer Composites Compatible with Human Hepatocytes | Q42808751 | ||
| Cholesterol-mediated anchoring of enzyme-loaded liposomes within disulfide-stabilized polymer carrier capsules | Q43291404 | ||
| Shape- and nitric oxide flux-dependent bactericidal activity of nitric oxide-releasing silica nanorods | Q44288565 | ||
| Designer bacteria as intratumoural enzyme biofactories. | Q45872008 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1701043 | |
| P577 | publication date | 2018-04-23 | |
| P1433 | published in | Advanced Science | Q25340053 |
| P1476 | title | Progress and Promise of Nitric Oxide-Releasing Platforms. | |
| P478 | volume | 5 |
| Q64119156 | Altered Venous Blood Nitric Oxide Levels at Depth and Related Bubble Formation During Scuba Diving |
| Q92889892 | Controlled release of H2S and NO gases through CO2-stimulated anion exchange |
| Q100533715 | Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway |
| Q97526382 | Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis |
| Q57452807 | Nitric oxide-releasing semi-crystalline thermoplastic polymers: preparation, characterization and application to devise anti-inflammatory and bactericidal implants |
Search more.